Koers GelStat Corp. Other OTC
Aandelen
GSAC
US3685331056
Farmaceutische producten
Omzet 2022 | 0 0 | Omzet 2023 | 0,15 0,14 | Marktkapitalisatie | 543K 501K |
---|---|---|---|---|---|
Nettowinst (verlies) 2022 | - 0 | Nettowinst (verlies) 2023 | - 0 | EV/omzet 2022 | 407.113.588 x |
Nettoschuld 2022 | 361K 333K | Nettoschuld 2023 | 559K 515K | EV/omzet 2023 | 7.367.338 x |
K/w-verhouding 2022 |
-0,74
x | K/w-verhouding 2023 |
-1,86
x | Werknemers | - |
Dividendrendement 2022 * |
-
| Dividendrendement 2023 |
-
| Vrij verhandelbaar | 129,4% |
Managers | Titel | Leeftijd | Van |
---|---|---|---|
Javier G. Acosta
CEO | Chief Executive Officer | - | - |
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Director/Board Member | 85 | 27-04-07 | |
Adrian Goldfarb
CHM | Chairman | 66 | 01-04-08 |
Paul W. Bucha
BRD | Director/Board Member | 81 | 04-11-11 |
Vaira. 1 jan. | Kapi. | |
---|---|---|
+37,78% | 723 mld. | |
+31,51% | 598 mld. | |
-3,51% | 364 mld. | |
+19,94% | 331 mld. | |
+5,14% | 288 mld. | |
+16,42% | 244 mld. | |
-4,62% | 208 mld. | |
+10,18% | 210 mld. | |
+9,32% | 169 mld. |